封面
市場調查報告書
商品編碼
1692385

血流改道動脈瘤治療市場-全球產業規模、佔有率、趨勢、機會和預測,按產品(FDS、囊內血流中斷裝置)、按最終用戶(醫院、專科診所)、按地區和競爭進行細分,2020-2030F

Flow Diversion Aneurysm Treatment Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (FDS, Intrasaccular flow disruption devices), By End User (Hospitals, Specialty clinics), By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球血流分流動脈瘤治療市場價值為 19.8 億美元,預計在預測期內將經歷顯著成長,到 2030 年的年複合成長率(CAGR) 為 7.72%。該市場在神經介入領域發展迅速,其驅動力是迫切需要解決一種可能危及生命的疾病—腦動脈瘤。該市場的特點是使用流量轉移裝置,這是一種微創治療方法,旨在將血流從動脈瘤中轉移出去,有助於動脈瘤的閉塞並降低破裂的風險。血流分流技術和神經影像技術的不斷進步正在拓寬治療選擇並改善患者的治療效果。腦動脈瘤發生率不斷上升,通常與老化和其他風險因素有關,這進一步推動了對有效治療方案的需求。與傳統手術方法相比,血流改道手術的侵入性較小,從而縮短了恢復時間並減少了住院時間。

市場概況
預測期 2026-2030
2024 年市場規模 19.8 億美元
2030 年市場規模 30.7 億美元
2025-2030 年複合年成長率 7.72%
成長最快的領域 軟骨發育不全
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

流量轉移裝置雖然非常有效,但價格昂貴,這些專門裝置的成本佔整體治療費用的很大一部分。

執行流量轉移程序需要專門的培訓,這會產生額外的教育和認證費用。

術前評估、延長住院時間和後續護理的複雜性也會增加整體醫療成本。

雖然設備和醫療工具的技術進步可能會帶來更好的結果,但也可能導致更高的前期成本。

主要市場趨勢

流量轉移裝置的持續創新,包括設計、材料和輸送系統的改進,提高了其安全性和有效性,進一步促進了其應用。

目錄

第 1 章:產品概述

第 2 章:研究方法

第 3 章:執行摘要

第 4 章:顧客之聲

第 5 章:全球血流分流動脈瘤治療市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品(FDS、囊內血流阻斷裝置)
    • 按最終用戶(醫院、專科診所)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖

第 6 章:北美血流分流動脈瘤治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 加拿大
    • 墨西哥

第 7 章:歐洲血流分流動脈瘤治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章:亞太地區血流分流動脈瘤治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章:南美洲血流分流動脈瘤治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 阿根廷
    • 哥倫比亞

第 10 章:中東和非洲血流分流動脈瘤治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 最新動態
  • 產品發布
  • 合併與收購

第 13 章:全球血流分流動脈瘤治療市場:SWOT 分析

第 14 章:競爭格局

  • Acandis GmbH
  • BALT Group
  • Cardinal Health Inc
  • Endologix LLC
  • Evasc Medical Systems Corp
  • Imperative Care Inc
  • InspireMD Inc
  • Johnson and Johnson
  • Lepu Medical Technology Beijing Co. Ltd
  • Medtronic Plc

第 15 章:策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 18929

The global Flow Diversion Aneurysm Treatment Market was valued at USD 1.98 billion in 2024 and is projected to experience significant growth during the forecast period, with a compound annual growth rate (CAGR) of 7.72% through 2030. This market is evolving rapidly within the neurointerventional sector, driven by the urgent need to address cerebral aneurysms, a potentially life-threatening condition. The market is characterized by the use of flow diversion devices, a minimally invasive treatment designed to reroute blood flow away from aneurysms, aiding in their occlusion and reducing the risk of rupture. Continuous advancements in flow diversion technologies and neuroimaging techniques are broadening treatment options and enhancing patient outcomes. The rising incidence of cerebral aneurysms, often linked to aging and other risk factors, is further propelling demand for effective treatment solutions. Compared to traditional surgical approaches, flow diversion procedures are less invasive, leading to shorter recovery times and reduced hospital stays.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.98 Billion
Market Size 2030USD 3.07 Billion
CAGR 2025-20307.72%
Fastest Growing SegmentFDS
Largest MarketNorth America

Key Market Drivers

The Flow Diversion Aneurysm Treatment Market is experiencing notable growth, primarily driven by the increasing adoption of minimally invasive treatment options. This trend reflects a shift in the management of cerebral aneurysms, prioritizing less invasive procedures over traditional open surgeries. Several factors contributing to this shift include:

Minimally invasive procedures typically require smaller incisions or access points, resulting in reduced tissue damage, less pain, and faster recovery times compared to open surgery. This approach is highly appealing to both patients and healthcare providers.

Flow diversion treatments yield excellent patient outcomes, with lower complication rates and reduced risks of infection or bleeding, which boosts patient satisfaction and enhances the reputation of these procedures.

Advances in medical devices and imaging technologies have made minimally invasive treatments more precise and effective. Real-time imaging guidance plays a critical role in increasing the accuracy of flow diversion procedures.

Key Market Challenges

Despite the promising growth of the market, high procedural costs remain a significant challenge. These costs encompass various aspects of treatment, including the price of flow diversion devices, hospital fees, physician charges, and post-procedure care. Contributing factors to the elevated costs include:

Flow diversion devices, while highly effective, can be expensive, and the cost of these specialized devices forms a substantial part of the overall treatment expenses.

Performing flow diversion procedures requires specialized training, which incurs additional costs for education and certification.

The complexity of pre-operative assessments, extended hospital stays, and follow-up care also increases overall healthcare costs.

While technological advancements in devices and medical tools may lead to better outcomes, they can also result in higher upfront costs.

Reimbursement rates for flow diversion procedures in some healthcare systems may not fully cover the costs, creating financial constraints for hospitals and healthcare providers. High procedural costs can also limit patient access to these advanced treatments.

Addressing these challenges requires a multi-pronged approach, including optimizing the cost-effectiveness of flow diversion devices, improving reimbursement strategies, and expanding access to specialized care. Overcoming these barriers is essential to ensuring equitable patient access to life-saving treatments and ensuring the sustainability of healthcare systems.

Key Market Trends

A growing adoption of flow diversion techniques is a prominent trend in the market, with an increasing preference for flow diversion procedures as the primary method for managing cerebral aneurysms. Key factors contributing to this trend include:

Flow diversion procedures are less invasive compared to traditional open surgeries, attracting patients seeking treatments that offer quicker recovery times, reduced pain, and smaller incisions.

Flow diversion techniques have proven to be highly effective in treating complex aneurysms, such as wide-necked and fusiform aneurysms, that were previously difficult to manage. This effectiveness has led to greater trust and acceptance among both physicians and patients.

Ongoing innovations in flow diversion devices, including improvements in design, materials, and delivery systems, have enhanced their safety and efficacy, further promoting adoption.

Patients undergoing flow diversion procedures often experience positive outcomes, including lower rates of aneurysm recurrence and fewer complications, contributing to higher patient satisfaction and confidence in the treatment.

An increasing number of neurointerventionalists are being trained in flow diversion techniques, expanding the availability of these procedures in medical centers globally. The growing body of clinical evidence supporting the effectiveness of flow diversion in preventing aneurysm rupture is further driving its adoption.

Key Market Players

  • Acandis GmbH
  • BALT Group
  • Cardinal Health Inc
  • Endologix LLC
  • Evasc Medical Systems Corp
  • Imperative Care Inc
  • InspireMD Inc
  • Johnson & Johnson
  • Lepu Medical Technology Beijing Co. Ltd
  • Medtronic Plc

Market Segmentation

This report segments the global Flow Diversion Aneurysm Treatment Market into the following categories:

By Product:

  • Flow Diverter Stents (FDS)
  • Intrasaccular Flow Disruption Devices

By End User:

  • Hospitals
  • Specialty Clinics

By Region:

  • North America (United States, Canada, Mexico)
  • Europe (France, United Kingdom, Italy, Germany, Spain)
  • Asia-Pacific (China, India, Japan, Australia, South Korea)
  • South America (Brazil, Argentina, Colombia)
  • Middle East & Africa (South Africa, Saudi Arabia, UAE)

Competitive Landscape

The report provides a detailed analysis of the major players in the Flow Diversion Aneurysm Treatment Market, including their strategies, market share, and key business developments.

Available Customizations

TechSci Research offers customizations for this global Flow Diversion Aneurysm Treatment Market report according to specific company needs. Customization options include:

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Flow Diversion Aneurysm Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (FDS, Intrasaccular flow disruption devices)
    • 5.2.2. By End User (Hospitals, Specialty clinics)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Flow Diversion Aneurysm Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Flow Diversion Aneurysm Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End user
    • 6.3.2. Canada Flow Diversion Aneurysm Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End user
    • 6.3.3. Mexico Flow Diversion Aneurysm Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End user

7. Europe Flow Diversion Aneurysm Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Flow Diversion Aneurysm Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End user
    • 7.3.2. United Kingdom Flow Diversion Aneurysm Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End user
    • 7.3.3. Italy Flow Diversion Aneurysm Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End user
    • 7.3.4. France Flow Diversion Aneurysm Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End user
    • 7.3.5. Spain Flow Diversion Aneurysm Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End user

8. Asia-Pacific Flow Diversion Aneurysm Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Flow Diversion Aneurysm Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End user
    • 8.3.2. India Flow Diversion Aneurysm Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End user
    • 8.3.3. Japan Flow Diversion Aneurysm Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End user
    • 8.3.4. South Korea Flow Diversion Aneurysm Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End user
    • 8.3.5. Australia Flow Diversion Aneurysm Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End user

9. South America Flow Diversion Aneurysm Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Flow Diversion Aneurysm Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End user
    • 9.3.2. Argentina Flow Diversion Aneurysm Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End user
    • 9.3.3. Colombia Flow Diversion Aneurysm Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End user

10. Middle East and Africa Flow Diversion Aneurysm Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Flow Diversion Aneurysm Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End user
    • 10.3.2. Saudi Arabia Flow Diversion Aneurysm Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End user
    • 10.3.3. UAE Flow Diversion Aneurysm Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisition

13. Global Flow Diversion Aneurysm Treatment Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Acandis GmbH
    • 14.1.1. Business Overview
    • 14.1.2. Treatment Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Key Personnel
    • 14.1.5. SWOT Analysis
  • 14.2. BALT Group
  • 14.3. Cardinal Health Inc
  • 14.4. Endologix LLC
  • 14.5. Evasc Medical Systems Corp
  • 14.6. Imperative Care Inc
  • 14.7. InspireMD Inc
  • 14.8. Johnson and Johnson
  • 14.9. Lepu Medical Technology Beijing Co. Ltd
  • 14.10.Medtronic Plc

15. Strategic Recommendations

16. About Us & Disclaimer